ARTV
Artiva Biotherapeutics, Inc. · Healthcare
RA CAPITAL MANAGEMENT, L.P. bought $2.6M of Artiva Biotherapeutics, Inc.
Director
Bought$2,583,314
$9.76Price
264,586Shares
+2%Stake
What ARTV did for a copier
- $1,000 copied at Fri, Jul 24 open, $10.52
- $1,034
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Sep 8 close.
RA CAPITAL MANAGEMENT, L.P.'s record
63 other buys with 3 months of prices since 2016: on average +0.5% against the S&P 500, and 23 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jul 21. Filed Thu, Jul 23, 9:22 PM ET, after the close. Returns use the Jul 24 open and the Sep 8 close. Not investment advice.